Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunotherapy for recurrent or persistent advanced cervical carcinoma refractory to platinum-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Carcinoma
• Persistent Advanced Cervical Carcinoma

Snippet

Sponsor: Lei Li | Conditions: Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma | Phase 2 | Status: COMPLETED